William Bertrand
2019
In 2019, William Bertrand earned a total compensation of $1.4M as Chief Operating Officer at Adaptimmune Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,282 |
|---|---|
| Option Awards | $766,900 |
| Salary | $432,640 |
| Other | $33,691 |
| Total | $1,369,513 |
Bertrand received $766.9K in option awards, accounting for 56% of the total pay in 2019.
Bertrand also received $136.3K in non-equity incentive plan, $432.6K in salary and $33.7K in other compensation.
Rankings
In 2019, William Bertrand's compensation ranked 7,787th out of 13,971 executives tracked by ExecPay. In other words, Bertrand earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,787 out of 13,971 | 44th |
Division Manufacturing | 3,059 out of 5,701 | 46th |
Major group Chemicals And Allied Products | 1,155 out of 2,200 | 48th |
Industry group Drugs | 987 out of 1,886 | 48th |
Industry Biological Products, Except Diagnostic Substances | 224 out of 389 | 42nd |
Source: SEC filing on April 20, 2020.
Bertrand's colleagues
We found four more compensation records of executives who worked with William Bertrand at Adaptimmune Therapeutics in 2019.